|
|
|
Volumn 50, Issue 1290, 2008, Pages 54-55
|
|
Wellbutrin versus generic bupropion
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BUDEPRION XL;
DOPAMINE UPTAKE INHIBITOR;
GENERIC DRUG;
NORADRENALIN UPTAKE INHIBITOR;
UNCLASSIFIED DRUG;
DEPRESSION;
DRUG APPROVAL;
DRUG COST;
DRUG DOSAGE FORM COMPARISON;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG RELEASE;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MENTAL DISEASE;
PRESCRIPTION;
PSYCHOPHARMACOTHERAPY;
RELAPSE;
SEDATION;
SEXUAL DYSFUNCTION;
SHORT SURVEY;
SIDE EFFECT;
SINGLE DRUG DOSE;
SUSTAINED RELEASE FORMULATION;
TABLET FORMULATION;
TREATMENT OUTCOME;
WEIGHT GAIN;
ARTICLE;
COMPARATIVE STUDY;
DELAYED RELEASE FORMULATION;
PHARMACOKINETICS;
UNITED STATES;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
BUPROPION;
DELAYED-ACTION PREPARATIONS;
DEPRESSION;
DOPAMINE UPTAKE INHIBITORS;
DRUG APPROVAL;
DRUGS, GENERIC;
HUMANS;
THERAPEUTIC EQUIVALENCY;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 49249116281
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (2)
|
